DOI: http://dx.doi.org/10.18203/2349-3933.ijam20211479

Test dosing as an alternative treatment approach in urinary tract infection patient with Cefoperazone allergy

I. Made Adi Narendranatha Komara, Ketut Suryana

Abstract


Drug hypersensitivity reaction (DHR) is classified as adverse reaction which is based on immunologic mediated reaction. Antibiotics are the most frequently prescribed drugs given to patients to treat bacterial infections, but also cause adverse drug reactions due to hypersensitivity in patients. We present here a case of cefoperazone drug allergy in a 75 years old patient with urinary tract infection requiring the test dosing approach.


Keywords


Drug hypersensitivity reaction, Test dosing, Urinary tract infection, Cefoperazone, Drug allergy

Full Text:

PDF

References


Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5(4):309-16.

Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-6.

Suryana K. Drug provocation test as a diagnostic approach for hypersensitivity reaction to antituberculosis drugs: a report of two cases. Asian J Pharm Clin Res. 2020;13(5):1-4.

Torres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017;7(7):7.

Pant ND, Acharya SP, Bhandari R, Bahadur DS, Sharma M, et al. Bacteremia and urinary tract infection caused by Chromobacterium violaceum: case report from a tertiary care hospital in Kathmandu, Nepal. Hindawi. 2017;1-4.

Kim MH, Lee JM. Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Allergy Asthma Immunol Res. 2014;6(6):485-95.

Jourdan A, Sangha B, Kim E. Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice. Allergy Asthma Clin Immunol. 2020;16:6.

Maker JH, Stroup CM, Huang V, James S. Antibiotic Hypersensitivity Mechanisms. Pharmacy (Basel). 2019;7(3):122.

Pichler WJ, Yerly D. Drug hypersensitivity: We need to do more. J Allergy Clin Immunol. 2018;141(1):89-91.

Pichler WJ. Drug Hypersensitivity. Basel, Karger. 2007;168–89.

Chaundhry SB, Veve MP, Wagner JL. Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity. Pharmacy (Basel). 2019;7:103.

Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med. 2001;345(11):804-9.

Chiriac AM, Demoly P. Drug provocation tests: up-date and novel approaches. Allergy, Asthma & Clinical Immunology. 2013;9(1):12.

Soyer O, Sahiner UM, Sekerel BE. Pro and Contra: Provocation Tests in Drug Hypersensitivity. Int. J. Mol. Sci. 2017;18(7):1437.

Garvey LH, Ebo DG, Krøigaard M, Savic S, Clarke R, Cooke P, et al. The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current status. Br J Anaesthesia. 2019;123(1):126-34.

Graded challenge guidance. NM Antimicrobial Stewardship. 2018. Available at: https://asp.nm.org/uploads/9/0/7/8/90789983/nm_graded_challenge_guidance_document_created8.5.19.pdf . Accessed on 23 January 2021.

Brotto V, Rafferty K. Clinical dosage calculations for Australia and New Zealand. 2nd ed. South Melbourne, Australia: Cengage Learning; 2019.

McGee EU, Samuel E, Boronea B, Dillard N, Milby M, Lewis SJ. Quinolone Allergy. Pharmacy (Basel). 2019;7(3):97.